Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan-Reference-Cited by-同舟云学术

Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan

Published:2018-01-03 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Sarwar Muhammad Rehan^ORCID,Iftikhar Sadia,Saqib Anum

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3980-3.pdf

Reference36 articles.

1. Albreht T, et al. Making progress against cancer in Europe in 2008. Eur J Cancer. 2008;44(10):1451–6.

2. Shahid Mahmood, et al., Annual cancer registry report-2016, of the Shaukat Khanum Memorial Cancer Hospital & Research Center, PAKISTAN. 2016: Pakistan.

3. Kantarjian HM, et al. Cancer drugs in the United States: Justum Pretium—the just price. J Clin Onco. 2013;31(28):3600–4.

4. Hillner BE, Smith TJ. Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. Proc Am Soc Clin Oncol. 2009;

5. Bhurgri Y, et al. Pakistan-country profile of cancer and cancer control 1995-2004. J Pak Med Assoc. 2006;56(3):124.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Awareness, Knowledge, and Attitude among Medical and Non-Medical Female Undergraduates: A Cross-Sectional Study;Indian Journal of Gynecologic Oncology;2024-08-24

2. Patents and Public Health: State Responsibility to Opt for a Balanced Approach;Societies;2024-08-13

3. Access to essential and innovative anti-cancer medicines: a longitudinal study in Nanjing, China;BMC Health Services Research;2024-07-11

4. Clinico-genomic findings, molecular docking, and mutational spectrum in an understudied population with breast cancer patients from KP, Pakistan;Frontiers in Genetics;2024-05-09

5. Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan;Neoplasia;2024-05